About Vycellix Sweden
Vycellix Sweden AB is a wholly-owned subsidiary of the USA-based biotechnology company, Vycellix, Inc. Vycellix Sweden is engaged in discovery-stage cancer immunotherapy research, which is conducted in collaboration with leading medical researchers at Sweden’s Karolinska Institutet. The Company’s mission is to discover and develop novel therapeutic products for the improved treatment of human disease with a focus on cancers.
Location:
The Company is based at the Karolinska Institute’s Flemingsberg campus in the ‘Innovation Station’ incubator:
Vycellix Sweden
c/o Innovation Station
Alfred Nobels allé 7
141 89 Huddinge
SWEDEN
➡️ Click Here to View Vycellix Sweden’s Gender Equality Plan